Abstract
Evidence has been presented which proves that dibenzanthracene is metabolized by the mouse into at least four substances, and some specUlations as to the sites of this degradation have been advanced. This paper is based upon work performed under Contract No. W-7405-Eng-48 with the Atomic Energy Commission in connection with the Radiation Laboratory, University of California, Berkeley. To be published in Cancer
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
